SI Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 1.23%, SMA50 -4.67%, SMA200 -2.27%). The stock’s 14-day RSI is 49.0 (neutral), while the ATR of 0.83 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -24.97% below its high and over 23.26% above its low. Average 10-day trading volume of 76.29 thousand shares is below the 3-month average of 123.82 thousand, indicating normal recent market interest.

Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $27.00 to $18.00. The high target offers 35.07% upside. The low target suggests -9.95% downside. The mean target is $22.33. This offers 11.71% upside. Shoulder Innovations, Inc. earnings surprise history is a mixed track record. The quarter that ended August 06, 2026, missed forecasts by 0.32%. The prior quarter beat by -6.82%. Over the last six quarters, Apple has recorded several small beats. These include 17563.01% in September 09, 2025.

Shoulder Innovations, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.26. This means the shares are trading below this model’s fair value.

Shoulder Innovations, Inc. (NYSE:SI) closed at $19.99 USD, losing -$0.33 (-1.62%) from the previous close of $20.32. The stock is currently mid-range between its 52-week high and low $10.92 and $24.59. With a market capitalization of about $414.56 million, Shoulder Innovations, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~-1.77). Key stats such as the average daily volume over the past year has been around 125.88 thousand shares, in line with its 52-week average. Headquartered in Grand Rapids, MI, Shoulder Innovations, Inc. operates in the Healthcare sector and the Medical - Specialties industry. Led by CEO Robert Joseph Ball, the company employs approximately 74 people and listed since July 31, 2025. Shoulder Innovations, Inc. manufactures medical devices.

Shoulder Innovations, Inc. trades at a P/E ratio of -11.67, slightly below the S&P 500 average, with a price-to-sales ratio of 6.89 and a price-to-book ratio of 3.33 trading at moderately above to book value. The P/FCF stands at -8.79, also below market averages.

Our AI price prediction model suggests that Shoulder Innovations, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.95%, with price expected at $20.18 by September 18, 2026, within a range of $18.65 to $21.77 3-Month Outlook: Projected rise of 67.78%, reaching $33.54 by December 03, 2026, with a range of $33.19 to $33.94. 1-Year Outlook: Projected gain of 46.22%, with price at $29.23 by September 03, 2027, within a range of $28.48 to $30.09.

Shoulder Innovations, Inc. (NYSE:SI) shares are flat -1.68% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Shoulder Innovations, Inc. trading at a premium to the broader market with a P/E of -11.67. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $20.90, suggesting 4.55% upside. Our AI forecast model points to short-term strength (0.95% over two weeks), a medium-term rise (67.78% over three months), and a longer-term gain (46.22% over one year), with expected trading ranges indicating moderate volatility.